Skip to main content Accessibility help
×
Home

Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment

  • S. E. Ladirat (a1), M. H. C. Schoterman (a2), H. Rahaoui (a3), M. Mars (a4), F. H. J. Schuren (a3), H. Gruppen (a1), A. Nauta (a2) and H. A. Schols (a1)...

Abstract

In the present double-blind, randomised, parallel intervention study, the effects of the intake of galacto-oligosaccharides (GOS) on the gut microbiota of twelve healthy adult subjects (aged 18–45 years with a normal BMI (18–25 kg/m2)) receiving amoxicillin (AMX) treatment were determined. All the subjects were treated with AMX (375 mg; three times per d) for 5 d and given either GOS (n 6) or placebo (maltodextrin, n 6) (2·5 g; three times per d) during and 7 d after AMX treatment. Faecal samples were collected twice before starting the treatment and on days 2, 5, 8, 12, 19 and 26. Due to AMX treatment, a decrease in the abundance of Bifidobacterium spp., an overgrowth of Enterobacteriaceae, and a disruption of the metabolic activity of the microbiota (increase in succinate, monosaccharide and oligosaccharide levels in the faecal samples) were observed in both groups (P< 0·05). Positive effects of GOS intake were observed on the levels of bifidobacteria, although not found to be significant. Data revealed that the levels of bifidobacteria were higher upon GOS intake than upon placebo intake, especially after AMX treatment. The activity of bifidobacteria and subsequent cross-feeding activity of the microbiota upon GOS intake compared with those upon placebo intake were reflected by the significant increase in butyrate levels (P< 0·05) in the faecal samples after AMX treatment. Despite the small number of subjects, our findings confirm previous results obtained in vitro, namely that GOS intake supports the recovery of the beneficial bifidobacteria and, indirectly, the production of butyrate after AMX treatment.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment
      Available formats
      ×

Copyright

Corresponding author

* Corresponding author: H. A. Schols, email henk.schols@wur.nl

References

Hide All
1 European Centre for Disease Prevention and Control (2010) Surveillance of antimicrobial consumption in Europe. http://ecdc.europa.eu/en/publications/Publications/antimicrobial-antibiotic-consumption-ESAC-report-2010-data.pdf (cited September 2013).
2 McFarland, LV (2008) Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol 3, 563578.
3 Gibson, GR, Probert, HM, Van Loo, J, et al. (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17, 259275.
4 Macfarlane, S, Macfarlane, GT & Cummings, JH (2006) Review Article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 24, 701714.
5 Saulnier, DM, Kolida, S & Gibson, GR (2009) Microbiology of the human intestinal tract and approaches for its dietary modulation. Curr Pharm Des 15, 14031414.
6 Macfarlane, GT & Macfarlane, LE (2009) Acquisition, evolution and maintenance of the normal gut microbiota. Dig Dis 27, 9098.
7 Ladirat, SE, Schuren, FH, Schoterman, MH, et al. (2014) Impact of galacto-oligosaccharides on the gut microbiota composition and metabolic activity upon antibiotic treatment during in vitro fermentation. FEMS Microbiol Ecol 87, 4151.
8 Alonso, VR & Guarner, F (2013) Linking the gut microbiota to human health. Br J Nutr 109, S21S26.
9 Willing, BP, Russell, SL & Finlay, BB (2011) Shifting the balance: antibiotic effects on host–microbiota mutualism. Nat Rev Microbiol 9, 233243.
10 De La Cochetière, MF, Durand, T, Lepage, P, et al. (2005) Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 43, 55885592.
11 Jeong, SH, Song, YK & Cho, JH (2009) Risk assessment of ciprofloxacin, flavomycin, olaquindox and colistin sulfate based on microbiological impact on human gut biota. Regul Toxicol Pharmacol 53, 209216.
12 Jalanka-Tuovinen, J, Salonen, A, Nikkilä, J, et al. (2011) Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS ONE 6, e23035.
13 Gibson, GR, Beatty, ER, Wang, X, et al. (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975982.
15 Davis, LMG, Martínez, I, Walter, J, et al. (2010) A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol 144, 285292.
16 Ladirat, SE, Schols, HA, Nauta, A, et al. (2013) High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition. J Microbiol Methods 92, 387397.
17 François, IEJA, Lescroart, O, Veraverbeke, WS, et al. (2012) Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial. Br J Nutr 108, 22292242.
18 Wanders, AJ, Mars, M, Borgonjen-van den Berg, KJ, et al. (2013) Satiety and energy intake after single and repeated exposure to gel-forming dietary fiber: post-ingestive effects. Int J Obes (Lond) (Epublication ahead of print version 13 September 2013).
19 World Health Organization (2013) Diarrhoea. http://www.who.int/topics/diarrhoea/en/ (cited September 2013).
20 Crielaard, W, Zaura, E, Schuller, AA, et al. (2011) Exploring the oral microbiota of children at various developmental stages of their dentition in the relation to their oral health. BMC Med Genomics 4, 22.
21 Albrecht, S, Schols, HA, Van Zoeren, D, et al. (2011) Oligosaccharides in feces of breast- and formula-fed babies. Carbohydr Res 346, 21732181.
22 Jonathan, MC, Bosch, G, Schols, HA, et al. (2013) Separation and identification of individual alginate oligosaccharides in the feces of alginate-fed pigs. J Agric Food Chem 61, 553560.
23 Saeed, AI, Sharov, V, White, J, et al. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34, 374378.
24 Eckburg, PB, Bik, EM, Bernstein, CN, et al. (2005) Microbiology: diversity of the human intestinal microbial flora. Science 308, 16351638.
25 Filteau, M, Matamoros, S, Savard, P, et al. (2013) Molecular monitoring of fecal microbiota in healthy adults following probiotic yogurt intake. PharmaNutrition 1, 123129.
26 Blaut, M & Clavel, T (2007) Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137, 751S755S.
27 Matsuki, T, Watanabe, K, Fujimoto, J, et al. (2004) Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 70, 167173.
28 Turroni, F, Ribbera, A, Foroni, E, et al. (2008) Human gut microbiota and bifidobacteria: from composition to functionality. Antonie van Leeuwenhoek 94, 3550.
29 Macfarlane, S & Macfarlane, GT (2003) Session: short-chain fatty acids. Regulation of short-chain fatty acid production. Proc Nutr Soc 62, 6772.
30 Wong, JMW, De Souza, R, Kendall, CWC, et al. (2006) Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40, 235243.
31 Sullivan, A (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1, 101114.
32 Bartosch, S, Fite, A, Macfarlane, GT, et al. (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70, 35753581.
33 Brunser, O, Gotteland, M, Cruchet, S, et al. (2006) Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment. Pediatr Res 59, 451456.
34 Dethlefsen, L & Relman, DA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108, 45544561.
35 Welling, P (1977) Influence of food and diet on gastrointestinal drug absorption: a review. J Pharmacokinet Biopharm 5, 291334.
36 Sekirov, I, Tam, NM, Jogova, M, et al. (2008) Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 76, 47264736.
37 Kovatcheva, PP, Zoetendal, EG, Venema, K, et al. (2009) Review: tools for the tract: understanding the functionality of the gastrointestinal tract. Therap Adv Gastroenterol 2, s9s22.
38 Newton, DF, MacFarlane, S & MacFarlane, GT (2013) Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms. Antimicrob Agents Chemother 57, 20162025.
39 Yap, IKS, Li, JV, Saric, J, et al. (2008) Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J Proteome Res 7, 37183728.
40 Belenguer, A, Duncan, SH, Calder, AG, et al. (2006) Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72, 35933599.
41 Louis, P & Flint, HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294, 18.
42 Jernberg, C, Löfmark, S, Edlund, C, et al. (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1, 5666.

Keywords

Type Description Title
PDF
Supplementary materials

Ladirat Supplementary Material
Figure S1

 PDF (154 KB)
154 KB

Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment

  • S. E. Ladirat (a1), M. H. C. Schoterman (a2), H. Rahaoui (a3), M. Mars (a4), F. H. J. Schuren (a3), H. Gruppen (a1), A. Nauta (a2) and H. A. Schols (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed